BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Indo US Bio-Tech Ltd Industry :  Miscellaneous
BSE Code
541304
ISIN Demat
INE250Z01010
Book Value (Rs)
46.1460203
NSE Symbol
INDOUS
Divident Yield %
0
Market Cap
(Rs In Cr.)
120
P/E (TTM)
10.51
EPS (TTM)
5.71
Face Value
(Rs)
10
Back
Indo US Bio-Tech standalone net profit declines 35.32% in the June 2026 quarter
12-Aug-26   Hrs IST

Net profit of Indo US Bio-Tech declined 35.32% to Rs 3.04 crore in the quarter ended June 2026 as against Rs 4.70 crore during the previous quarter ended June 2025. Sales rose 7.21% to Rs 32.99 crore in the quarter ended June 2026 as against Rs 30.77 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales32.9930.77 7
OPM %12.0317.78 -
PBDT3.355.02 -33
PBT3.084.82 -36
NP3.044.70 -35

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)